Oral form of Taxol cancer drug successfully developed.

Published: 2006-04-26 06:56:00
Updated: 2006-04-26 06:56:00
An oral dosage form of Taxol, an anti-cancer drug, has been newly developed with much less adverse reactions.

In the 3rd Joint Korea and Japan International symposium at Hoam faculty club house, SNU sponsored by the Korea Society of Pharmaceutics on April 20, Dr. Chung Hae-seon of KIST present...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.